37682502|t|PPARalpha Ligand Caudatin Improves Cognitive Functions and Mitigates Alzheimer's Disease Defects By Inducing Autophagy in Mice Models.
37682502|a|The autophagy-lysosomal pathway (ALP) is a major cellular machinery involved in the clearance of aggregated proteins in Alzheimer disease (AD). However, ALP is dramatically impaired during AD pathogenesis via accumulation of toxic amyloid beta (Abeta) and phosphorylated-Tau (phospho-Tau) proteins in the brain. Therefore, activation of ALP may prevent the increased production of Abeta and phospho-Tau in AD. Peroxisome proliferator-activated receptor alpha (PPARalpha), a transcription factor that can activate autophagy, and transcriptionally regulate transcription factor EB (TFEB) which is a key regulator of ALP. This suggests that targeting PPARalpha, to reduce ALP impairment, could be a viable strategy for AD therapy. In this study, we investigated the anti-AD activity of Caudatin, an active constituent of Cynanchum otophyllum (a traditional Chinese medicinal herb, Qing Yang Shen; QYS). We found that Caudatin can bind to PPARalpha as a ligand and augment the expression of ALP in microglial cells and in the brain of 3XTg-AD mice model. Moreover, Caudatin could activate PPARalpha and transcriptionally regulates TFEB-augmented lysosomal degradation of Abeta and phosphor-Tau aggregates in AD cell models. Oral administration of Caudatin decreased AD pathogenesis and ameliorated the cognitive dysfunction in 3XTg-AD mouse model. Conclusively, Caudatin can be a potential AD therapeutic agent via activation of PPARalpha-dependent ALP.
37682502	0	9	PPARalpha	Gene	19013
37682502	17	25	Caudatin	Chemical	MESH:C570806
37682502	69	96	Alzheimer's Disease Defects	Disease	MESH:D000544
37682502	255	272	Alzheimer disease	Disease	MESH:D000544
37682502	274	276	AD	Disease	MESH:D000544
37682502	324	326	AD	Disease	MESH:D000544
37682502	380	385	Abeta	Gene	11820
37682502	516	521	Abeta	Gene	11820
37682502	541	543	AD	Disease	MESH:D000544
37682502	545	593	Peroxisome proliferator-activated receptor alpha	Gene	19013
37682502	595	604	PPARalpha	Gene	19013
37682502	690	713	transcription factor EB	Gene	21425
37682502	715	719	TFEB	Gene	21425
37682502	783	792	PPARalpha	Gene	19013
37682502	804	818	ALP impairment	Disease	MESH:D016464
37682502	851	853	AD	Disease	MESH:D000544
37682502	903	905	AD	Disease	MESH:D000544
37682502	918	926	Caudatin	Chemical	MESH:C570806
37682502	989	1011	Chinese medicinal herb	Chemical	-
37682502	1013	1027	Qing Yang Shen	Chemical	-
37682502	1070	1079	PPARalpha	Gene	19013
37682502	1166	1170	3XTg	CellLine	CVCL:C6V6
37682502	1171	1173	AD	Disease	MESH:D000544
37682502	1220	1229	PPARalpha	Gene	19013
37682502	1262	1266	TFEB	Gene	21425
37682502	1302	1307	Abeta	Gene	11820
37682502	1339	1341	AD	Disease	MESH:D000544
37682502	1378	1386	Caudatin	Chemical	MESH:C570806
37682502	1397	1399	AD	Disease	MESH:D000544
37682502	1433	1454	cognitive dysfunction	Disease	MESH:D003072
37682502	1458	1462	3XTg	CellLine	CVCL:C6V6
37682502	1463	1465	AD	Disease	MESH:D000544
37682502	1493	1501	Caudatin	Chemical	MESH:C570806
37682502	1521	1523	AD	Disease	MESH:D000544
37682502	1560	1569	PPARalpha	Gene	19013
37682502	Association	MESH:D000544	19013
37682502	Negative_Correlation	MESH:C570806	MESH:D003072
37682502	Negative_Correlation	MESH:C570806	MESH:D000544
37682502	Association	MESH:D000544	11820
37682502	Association	MESH:C570806	19013
37682502	Association	MESH:D016464	19013
37682502	Association	11820	21425

